Literature DB >> 27207988

Ochronosis of the knee with secondary osteoarthritis requiring total knee replacement in a patient with cryptogenic organising pneumonia.

Jorrit Jasper1, Wieneke Metsaars1, Joris Jansen1.   

Abstract

Ochronosis is a rare autosomal recessive metabolic disease caused by homogentisic acid oxidase enzyme deficiency. High homogentisic acid levels will eventually result in black deposits in skin, sclerae, connective tissues and urine (alkaptonuria). It can lead to early degeneration of connective tissues and cartilage. Ochronosis can damage normal cartilage, leading to secondary osteoarthritis. The diagnosis is often delayed because of its low prevalence and non-specific early symptoms. In our patient, the secondary osteoarthritis due to ochronosis deposits in the cartilage was treated by total knee arthroplasty, with good clinical outcome. This article reports the first case of ochronosis with secondary osteoarthritis of the knee in a patient previously diagnosed with cryptogenic organising pneumonia (COP). 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27207988      PMCID: PMC4885480          DOI: 10.1136/bcr-2016-215412

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Alkaptonuria diagnosed by flexible bronchoscopy.

Authors:  Joseph G Parambil; Craig E Daniels; Kenton J Zehr; James P Utz
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

2.  Ochronotic arthritis: case reports and review of the literature.

Authors:  Ercan Cetinus; Ilhan Cever; Cemal Kural; Haldun Erturk; Mustafa Akyildiz
Journal:  Rheumatol Int       Date:  2004-12-03       Impact factor: 2.631

Review 3.  Ochronotic arthropathy: diagnosis and management: a critical review.

Authors:  Emmanouil Drakoulakis; Dimitrios Varvitsiotis; Georgioss Psarea; John Feroussis
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2012-02

Review 4.  New developments in ochronosis: review of the literature.

Authors:  Julie M Keller; William Macaulay; Ohannes A Nercessian; Israeli A Jaffe
Journal:  Rheumatol Int       Date:  2004-08-21       Impact factor: 2.631

Review 5.  Recent advances in management of alkaptonuria (invited review; best practice article).

Authors:  Lakshminarayan R Ranganath; Jonathan C Jarvis; James A Gallagher
Journal:  J Clin Pathol       Date:  2013-03-13       Impact factor: 3.411

6.  Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion.

Authors:  K Forslind; F A Wollheim; B Akesson; U Rydholm
Journal:  Clin Exp Rheumatol       Date:  1988 Jul-Sep       Impact factor: 4.473

7.  The success of dietary protein restriction in alkaptonuria patients is age-dependent.

Authors:  V de Haas; E C Carbasius Weber; J B de Klerk; H D Bakker; G P Smit; W A Huijbers; M Duran; B T Poll-The
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

8.  The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria.

Authors:  A M Taylor; A Boyde; P J M Wilson; J C Jarvis; J S Davidson; J A Hunt; L R Ranganath; J A Gallagher
Journal:  Arthritis Rheum       Date:  2011-12
  8 in total
  1 in total

1.  Long-term follow-up of bilateral hip and knee arthroplasty secondary to ochronotic arthropathy.

Authors:  Imran Ilyas; Syed Kashif; Majed F Algashiri; Samar A Rabbani; Sahar S Aldakhil; Omar A Al-Mohrej
Journal:  Arthroplast Today       Date:  2020-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.